Literature DB >> 12366777

Major histocompatibility complex class I-restricted antigen processing and presentation.

L Van Kaer1.   

Abstract

Major histocompatibility complex (MHC) class I molecules present antigenic peptides to CD8-expressing cytotoxic T lymphocytes (CTLs). This antigen recognition system is critically important for immune surveillance against viruses and tumors. Most class I-binding peptides are generated in the cytosol, as side products from the degradation of misfolded proteins by proteasomes. A subset of the resulting peptides are translocated across the endoplasmic reticulum (ER) membrane by a dedicated peptide transporter, and these peptides are then loaded onto peptide-receptive class I molecules in the ER. The stable assembly of class I molecules with peptides is controlled by a variety of accessory proteins, including chaperones with general housekeeping functions and factors with dedicated roles in class I assembly. Peptide-filled class I molecules are then delivered to the cell surface for recognition by CTLs. This highly regulated process permits the host to rapidly counter invading pathogens with strong and sustained CTL responses and, at the same time, avoid misguided attacks. Here, how the class I antigen processing machinery accomplishes this daunting task is reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12366777     DOI: 10.1034/j.1399-0039.2002.600101.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  21 in total

1.  The design and implementation of the immune epitope database and analysis resource.

Authors:  Bjoern Peters; John Sidney; Phil Bourne; Huynh-Hoa Bui; Soeren Buus; Grace Doh; Ward Fleri; Mitch Kronenberg; Ralph Kubo; Ole Lund; David Nemazee; Julia V Ponomarenko; Muthu Sathiamurthy; Stephen P Schoenberger; Scott Stewart; Pamela Surko; Scott Way; Steve Wilson; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-14       Impact factor: 2.846

2.  The efficacy of antigen processing is critical for protection against cytomegalovirus disease in the presence of viral immune evasion proteins.

Authors:  Rafaela Holtappels; Doris Thomas; Matthias J Reddehase
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

Review 3.  Role of autophagy in MHC class I-restricted antigen presentation.

Authors:  Luc Van Kaer; Vrajesh V Parekh; J Luke Postoak; Lan Wu
Journal:  Mol Immunol       Date:  2017-11-08       Impact factor: 4.407

Review 4.  Pathogenesis of ankylosing spondylitis.

Authors:  Lai-Shan Tam; Jieruo Gu; David Yu
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

5.  Reduced expression of members of the mhc-i antigen processing machinery in ethnic Uighur women with cervical cancer in the Xinjiang region of China.

Authors:  A Haimiti; Y Hailiman; A Gulina; J Du; Z Hao; X L Rong; A Zainuer; W Qin; S Lalai
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

6.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.

Authors:  Jean-Pierre Routy; Mohamed-Rachid Boulassel; Bader Yassine-Diab; Charles Nicolette; Don Healey; Renu Jain; Claire Landry; Oleg Yegorov; Irina Tcherepanova; Tamara Monesmith; Lothar Finke; Rafick-Pierre Sékaly
Journal:  Clin Immunol       Date:  2009-11-04       Impact factor: 3.969

8.  Redox-regulated export of the major histocompatibility complex class I-peptide complexes from the endoplasmic reticulum.

Authors:  Sungwook Lee; Boyoun Park; Kwonyoon Kang; Kwangseog Ahn
Journal:  Mol Biol Cell       Date:  2009-05-28       Impact factor: 4.138

9.  Three tapasin docking sites in TAP cooperate to facilitate transporter stabilization and heterodimerization.

Authors:  Ralf M Leonhardt; Parwiz Abrahimi; Susan M Mitchell; Peter Cresswell
Journal:  J Immunol       Date:  2014-02-05       Impact factor: 5.422

Review 10.  Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.

Authors:  Vito Amodio; Gianluca Mauri; Nicole M Reilly; Andrea Sartore-Bianchi; Salvatore Siena; Alberto Bardelli; Giovanni Germano
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.